Table 1.
Ratings of diabetes experts of study effects and associated risk reductions of late complications in relation to format of data presentation
| Rating the benefit of the intervention as | Estimates of corresponding reductions of late complications | ||||||||
| very important | important | not very important | not important at all | >75% | 55–75% | 35–55% | 15–35% | <15% | |
| Diabetes prevention | |||||||||
| 60% diabetes risk reduction (item 1 and 2) |
35/15 (51%) |
19/14 (33%) |
8/1 (9%) |
6/1 (7%) |
7/5 (12%) |
14/8 (23%) |
9/5 (14%) |
11/7 (19%) |
25/6 (32%) |
| HbA1c 6.0% versus 6.1% (item 6 and 7) |
1/1 (2%) |
10/7 (17%) |
35/15 (51%) |
22/8 (30%) |
1/1 (2%) |
8/2 (10%) |
14/5 (19%) |
8/5 (13%) |
37/18 (56%) |
| 0.288 life years gained (item 5) |
3/3 (6%) |
17/9 (27%) |
34/15 (50%) |
13/4 (17%) |
n.a. | n.a. | n.a. | n.a. | n.a. |
| UKPDS | |||||||||
| HbA1c 7.0% versus 7.9% (item 3 and 4) |
22/12 (35%) |
24/15 (40%) |
21/4 (25%) |
0/0 | 2/2 (4%) |
7/4 (12%) |
20/6 (27%) |
22/13 (37%) |
13/6 (20%) |
| 41 versus 46 out of 100 patients (item 8) |
5/4 (9%) |
36/17 (54%) |
25/10 (36%) |
1/0 (1%) |
n.a. | n.a. | n.a. | n.a. | n.a. |
Values are numbers of the n = 69 Austrian/n = 31 German samples (percentages of all respondents). UKPDS = United Kingdom Prospective Diabetes Study [10]. Numbers may not add up to 100 due to up to 5 missing values. n.a. = not assessed